Discovery of a potential new therapy for inflammatory arthritis

Susan Rivers was only 10 years old when she began experiencing pain in the joints in her legs.

After many years of suffering and few answers, Susan was diagnosed with ankylosing spondylitis, a painful and inflammatory form of axial spondyloarthritis (SpA), which affects one per cent to two per cent of Canadians and causes inflammation in the spine, joints, eyes, gut and skin.

In a new paper recently published in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute at UHN (and supported by the Arthritis Society) have made a discovery that could lead to new treatments for SpA.

Share